In addition, mast cells, frequently activated by LL-37, have been reported to contribute to the pathogenesis of rosacea by releasing pro-inflammatory and pro-angiogenic mediators, including VEGF, thus linking innate immune responses to vascular abnormalities [15,16]. The gene discussed is VEGFA; the disease is rosacea.